The estimated effectiveness of the respiratory syncytial virus (RSV) among older US veterans in the 2023-2024 respiratory ...

As of Jan. 20, the CDC reports that RSV activity has peaked in most of the U.S., particularly among young children—a group ...

Shionogi’s respiratory syncytial virus (RSV) antiviral for adults has proven its ability to reduce viral load in a phase 2 ...

While RSV isn’t any more virulent than the cold, flu or COVID, the same precautions are recommended in order to control its ...

The 30-day risk for death was slightly higher for COVID-19 than for influenza or RSV; the 180-day mortality also was higher for COVID-19.

2 While often linked to infants and young children, RSV poses an even greater risk to older adults due to age and underlying health conditions, potentially leading to severe respiratory illness.

The following is a summary of “Respiratory syncytial virus vaccine effectiveness among US veterans, September, 2023 to March, 2024: a target trial emulation study,” published in the January 2025 issue ...

It is a potentially fatal virus that can lead to hospitalisations and death in infants, but also in elderly and chronically ill adults. Two RSV vaccines were approved for use in Australia last ...

Weekly case counts for the two respiratory illnesses have spiked in Erie County since Christmas, rising from a few dozen each in late December to 268 RSV cases and 321 flu cases the week ending Jan.

The prescribing information for two respiratory syncytial virus (RSV) vaccines will now include a warning for the increased ...